He is a listed applicant on a patent application in relation to the use of fenofibrate for treatment of diabetic retinopathy. He holds no shares, stocks or options in any pharmaceutical company.

Fenofibrate and its active metabolite, fenofibric acid, are primarily excreted by the kidneys. It is nondialysable, and studies in patients with moderate chronic kidney disease (GFR <50 ml/min/1. ...

ANI Pharmaceuticals ANIP has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives ...

They demonstrate the therapeutic potential of intervening in this process using the PPARα agonist fenofibrate. How stresses result in cellular senescence is not fully understood. Here ...

Apr. 2, 2024 — Changes in the gut microbiome have been implicated in a range of diseases including type 2 diabetes, obesity, and inflammatory bowel disease. Now, a team of researchers has found ...

Diabetes can affect many major organs, including your heart, eyes, kidneys, and brain. When the disease isn't well-controlled, it can lead to many serious comorbidities, which are conditions that ...

It's common to have high triglyceride levels if you have type 2 diabetes. When they are above the normal range, your provider might tell you that your triglyceride levels are elevated. Up to 70% of ...